CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 74 filers reported holding CYTOSORBENTS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $50,000 | -23.1% | 12,894 | 0.0% | 0.00% | -40.0% |
| Q3 2019 | $65,000 | -23.5% | 12,894 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $85,000 | -13.3% | 12,894 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $98,000 | -5.8% | 12,894 | 0.0% | 0.01% | -20.0% |
| Q4 2018 | $104,000 | -37.3% | 12,894 | 0.0% | 0.01% | -37.5% |
| Q3 2018 | $166,000 | – | 12,894 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |